 | Dosage Forms: Making Decisions Early in Development
Jeffrey K. Turns
Vice President, Sales & Marketing
Vetter
|
|
|
 | Innovation in a Maturing Biologicals Industry
Mike Kowolenko, PhD
Senior Vice President, Biotech Operating Unit
TO&PS
Wyeth Pharmaceuticals
|
|
|
 | Is Biomanufacturing the Next Product-Enabling Technology?
Marco Cacciuttolo, PhD
Chief Executive Officer
Percivia
|
|
|
 | Protein Production Systems at an Industrial Scale
Amine Kamen, PhD
Head, Animal & Cell Technology
National Research Council Canada, Biotech Research Institute
|
|
|
 | Protein Production Systems at an Industrial Scale
Charles Squires, PhD
Sr. Director, Biopharmaceutical Services
Dow Chemical
|
|
|
MANUFACTURING STRATEGIES interviews
Thursday, June 19th |
 |
|
|
 | Accelerating Cell Line Selection / Therapeutic Proteins & MAbs
Nicholas Barthelemey
Senior Vice President, Cell Systems Division
Invitrogen
|
|
|
 | Best Practices in Supply-Chain Risk Mitigation
Roger Estrella
Director of Supplier Risk Management
Genentech
|
|
|
 | Best Practices in Supply-Chain Risk Mitigation
Steve Faass, PhD
Vice President, Global Operation, Cell Systems Division
Invitrogen
|
|
|
 | Best Practices in Supply-Chain Risk Mitigation
Robert Sheppard
Director of Global Materials Management
Biogen Idec
|
|
|
 | Disposables for Bioprocessing: Making the Transition
Roberta Morris
Director Of Marketing
Charter Medical Ltd
|
|
|
 | Disposable Technology in Biopharmaceutical Dev & Mfg
David Radspinner, PhD
Director, Global Mktg & Customer Applications, Bioprocess Prod.
Thermo Fisher Scientific
|
|
|
 | Innovation in a Maturing Biologicals Industry
Al Dadson
Sr. Director, Fermentation Development & Manufacturing
Xoma
|
|
|
 | Is Biomanufacturing the Next Product-Enabling Technology?
Hubie Scoble, PhD
Assistant Vice President, Andover Development Site Head
Wyeth Biotech
|
|
|
 | Maximizing Productivity in Bioprocessing & Reducing Costs
Andy Topping, PhD
R&D Director of Early Phase Development
Avecia Biologics
|
|
|
 | Manufacturing for Biodefense Applications
Rob Tenerowicz
Vice President of Operations and Biodefense
Xoma
|
|
|
 | Protein Production Systems at an Industrial Scale
Tony D´Amore, PhD
Vice President, Process Development Canada
Sanofi Pasteur
|
|
|
|
|
![[Get Copyright Permissions]](http://license.icopyright.net/images/icopy-w.gif){kind=small}
